Data as of Dec 04
| +0.05 / +0.20%|
The 4 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 33.50, with a high estimate of 35.00 and a low estimate of 30.00. The median estimate represents a +34.48% increase from the last price of 24.91.
The current consensus among 4 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.